Storia in 1 fonti

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

Raccontata da

theguardian.com

Timeline cronologica

martedì 17 giugno 2025·theguardian.com
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’